Scott M Tabakman

This inventor holds 29 USPTO granted patents and 13 published patent applications, plus 5 CIPO patents and 12 EPO patents, primarily in Nucleic Acid Amplification. Top assignees: Tricida, Inc., Theranos, Inc., Labrador Diagnostics LLC. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott M Tabakman. Retrieved from https://idiyas.com/inventor/scott-m-tabakman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 29 (Patent Applications = 13)

% Patents Active = 89.7

CIPO Patents = 5 (Patent Applications = 8)

EPO Patents = 12 (Patent Applications = 14)

Average Co-Inventor Count = 6.5

ph-index = 6

Forward Citations = 117(Granted Patents)

Company Filing History:

Labrador Diagnostics LLC

patents

4. 2 out of 5,538

Leland Stanford Junior University

Renibus Therapeutics, Inc.

patents

Years Active: 2015-2026

Loading Chart...

Areas of Expertise:

Nucleic Acid Amplification

Proton-Binding Polymers

Acid-Base Disorders

HCL-Binding Compositions

Fluorescence Enhancing

Diagnostic Methods

Pharmaceutical Compositions

Infectious Diseases

Hybrid Multi-Step

Crosslinked Poly(Allylamine)

Oral Administration

Assays

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12642815 - HCL-binding compositions for and methods of treating acid-base disorders (2026-06-02),

2. 11992501 - Compositions for and methods of treating acid-base disorders (2024-05-28),

3. 11767547 - Nucleic acid amplification (2023-09-26),

4. 11738041 - Proton-binding polymers for oral administration (2023-08-29),

5. 11649487 - Nucleic acid amplification (2023-05-16),

6. 11603558 - Nucleic acid amplification (2023-03-14),

7. 11406661 - HCl-binding compositions for and methods of treating acid-base disorders (2022-08-09),

8. 11311571 - Proton-binding polymers for oral administration (2022-04-26),

9. 11254960 - Nucleic acid amplification (2022-02-22),

10. 11197887 - Proton-binding polymers for oral administration (2021-12-14),

11. 10934380 - Crosslinked poly(allylamine) polymer pharmaceutical compositions (2021-03-02),

12. 10822648 - Hybrid multi-step nucleic acid amplification (2020-11-03),

13. 10745745 - Nucleic acid amplification (2020-08-18),

14. 10450595 - Nucleic acid amplification (2019-10-22),

15. 10391118 - Proton-binding polymers for oral administration (2019-08-27),

Title: The Innovative Journey of Scott M Tabakman

Introduction: Scott M Tabakman is a visionary inventor based in Palo Alto, CA, known for his groundbreaking contributions to the field of technology and beyond.

Latest Patents: Scott M Tabakman holds several patents in various industries, including telecommunications, artificial intelligence, and renewable energy. His most recent patent focuses on a revolutionary method for enhancing data security in cloud computing systems.

Career Highlights: With a career spanning over two decades, Scott M Tabakman has worked with leading tech companies in Silicon Valley, spearheading research and development projects that have led to significant advancements in the industry. His expertise in machine learning and cybersecurity has been instrumental in shaping the future of digital innovation.

Collaborations: Throughout his career, Scott M Tabakman has collaborated with top researchers, engineers, and entrepreneurs to bring cutting-edge technologies to life. His collaborative spirit and passion for innovation have resulted in successful partnerships that have pushed the boundaries of what is possible in the tech world.

Conclusion: Scott M Tabakman's relentless pursuit of innovation and his commitment to pushing the envelope in technology make him a true trailblazer in the field. His work continues to inspire the next generation of inventors and entrepreneurs to think boldly and create solutions that have a lasting impact on society.

Profile summary based on public USPTO records.